AI Reputation Analysis and Signal Evaluation – Neulasta (Amgen)

B
Reputation Level
Medical Devices, Pharma & Biotech
59.3 Avg Reputation

Based on 784 businesses audited.

Brand AI Reputation

Medical Devices, Pharma & Biotech Reputation: Neulasta (Amgen) (neulasta.com)

https://neulasta.com 📍 Industry: Medical Devices, Pharma & Biotech
74 Reputation / 100

This is a substance-heavy pharmaceutical site where the BS score is suppressed by strict regulatory compliance and clinical data. The primary indicators of bullshit are technical (missing schema and H1 tags) and the presence of unverified ‘trust theatre’ metrics like unlinked patient satisfaction percentages.

Info Density Power-words vs. Substance ratio.
24 80% Reputation
View evidence →
Semantic Coherence Homepage promise vs. Sub-page reality.
20 100% Reputation
View evidence →
Trust & Proof Verifiable evidence vs. Trust Theatre.
10 50% Reputation
View evidence →
Commodity Fingerprint Detection of industry clichés/templates.
12 80% Reputation
View evidence →
Identity & Authority Expert verifiability & Schema depth.
8 53% Reputation
View evidence →

Medical Devices, Pharma & Biotech Reputation: Neulasta (Amgen) (neulasta.com)

Reputation: 74 / 100

The site is an exact match for the Pharma and Biotech category, utilizing highly specialized medical terminology such as febrile neutropenia (FN), granulocyte colony-stimulating factor (G-CSF), and myelosuppressive chemotherapy. The content structure is dictated by regulatory requirements, focusing on the mechanism of action and therapeutic area of pegfilgrastim.

“The score of 74 represents low BS. The score was driven up by the trust_and_proof pillar (10 points) due to the presence of unverified review counts and the identity_and_authority pillar (7 points) due to the complete lack of structured data. Information density is high, but the repetitive nature of the content prevented a perfect score in that category.”

Verified Analysis Date: May 30, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result